Study of the Combination of CM082 With JS001 in Patients With Advanced Mucosal Melanoma.

NCT03602547 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Mucosal Melanoma

Interventions

DRUG: CM082 plus JS001

Sponsor

AnewPharma